{"id":5597,"date":"2017-11-13T13:22:28","date_gmt":"2017-11-13T12:22:28","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/unkategorisiert\/path-to-security-detailed-risk-assesments\/"},"modified":"2022-06-17T07:53:03","modified_gmt":"2022-06-17T05:53:03","slug":"path-to-security-detailed-risk-assesments","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/","title":{"rendered":"Path to Security &#8211; Detailed Risk Assesments"},"content":{"rendered":"<p>Der <a href=\"https:\/\/www.bsi.bund.de\/DE\/Presse\/Pressemitteilungen\/Presse2017\/Bericht_zur_Lage_der_IT-Sicherheit_in_Deutschland_08112017.html\">aktuell ver\u00f6ffentlichte Bericht<\/a> des <a href=\"https:\/\/www.bsi.bund.de\/DE\/DasBSI\/dasbsi_node.html\">Bundesamtes f\u00fcr Sicherheit in der Informationstechnik (BSI)<\/a> macht sehr deutlich, dass in puncto Security ein <a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/automation-security-der-grosse-knall-droht\/\">enormer Handlungsbedarf<\/a> besteht! Die Zahl der bekannten Schadprogramme liegt mittlerweile bei ca. 620 Mio., (Stand Mai 2017, Quelle: AV-TEST, <a href=\"https:\/\/www.bsi.bund.de\/SharedDocs\/Downloads\/DE\/BSI\/Publikationen\/Lageberichte\/Lagebericht2017.pdf?__blob=publicationFile&amp;v=3#page=21&amp;zoom=auto,-98,569#page=21\">BSI Publikation Lagebericht 2017<\/a>). Deswegen ben\u00f6tigt die Industrie intelligente, individuelle, ma\u00dfgeschneiderte, vielschichtige L\u00f6sungskonzepte, die Ihnen eine wirksame Anlagensicherheit gew\u00e4hren.<\/p>\n<p>Auch die <a href=\"http:\/\/www.namur.net\/\">NAMUR<\/a> besch\u00e4ftigt sich aktuell mit der Frage, wie eine IT-Risikobeurteilung f\u00fcr PLT-Sicherheitseinrichtungen aussehen k\u00f6nnte, so vorgestellt auf der <a href=\"https:\/\/www.process.vogel.de\/namur-hauptsitzung-2017-spannungen-garantiert-a-661569\/?cmp=nl-98&amp;uuid=AA18F114-B288-4D20-A415CD362A9B576F\">NAMUR-Hauptsitzung 2017<\/a> von Herr Kruschitz.<\/p>\n<blockquote class=\"twitter-tweet\" data-lang=\"de\">\n<p dir=\"ltr\" lang=\"de\">Erwin Kruschitz von <a href=\"https:\/\/twitter.com\/hashtag\/Anapur?src=hash&amp;ref_src=twsrc%5Etfw\">#Anapur<\/a> auf <a href=\"https:\/\/twitter.com\/hashtag\/Namur_HS?src=hash&amp;ref_src=twsrc%5Etfw\">#Namur_HS<\/a>: <a href=\"https:\/\/twitter.com\/hashtag\/Security?src=hash&amp;ref_src=twsrc%5Etfw\">#Security<\/a> als Voraussetzung f\u00fcr <a href=\"https:\/\/twitter.com\/hashtag\/DigitaleTransformation?src=hash&amp;ref_src=twsrc%5Etfw\">#DigitaleTransformation<\/a>. Petya zeigte: Es trifft auch die Guten <a href=\"https:\/\/t.co\/z3eP1Cw9TH\">pic.twitter.com\/z3eP1Cw9TH<\/a><\/p>\n<p>\u2014 Ronald Heinze (@Ronald_Heinze) <a href=\"https:\/\/twitter.com\/Ronald_Heinze\/status\/928571900732813312?ref_src=twsrc%5Etfw\">9. November 2017<\/a><\/p><\/blockquote>\n<h2><strong>Was sind die wichtigen ersten Meilensteine zur Anlagensicherheit?<\/strong><\/h2>\n<p>Zun\u00e4chst muss nat\u00fcrlich eine generelle Sensibilisierung der Mitarbeiter zur Cyber Security-Thematik geschaffen werden. Hierf\u00fcr eignen sich <a href=\"https:\/\/www.yokogawa-seminare.de\/seminare\/automation-security\/\">Trainings<\/a> hervorragend, um die aktuellen Methoden und Varianten der Angreifer den Mitarbeiter zu zeigen. Wie Cyberkriminelle <a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/schadsoftware-getarnt-als-trojanisches-pferd\/\">Schadsoftware installieren<\/a> oder an h\u00f6chst sensible Daten gelangen.<\/p>\n<p>Danach gilt es, pr\u00e4ventiv die komplette Infrastruktur des Unternehmens oder des gesamten Konzerns mittels eines Detailed Risk Assesments (DRA) zu detektieren. Schwachstellen der technischen Infrastruktur werden somit fr\u00fchzeitig erkannt.<\/p>\n<h2><strong>Detailed Risk Assesments f\u00fcr die BASF in Asien und Amerika<\/strong><\/h2>\n<p>Von der BASF SE, Ludwigshafen, erhielten wir den Auftrag, <a href=\"http:\/\/www.yokogawa.com\/de\/unternehmen\/presse\/2017\/PM_BASF_Yokogawa.pdf\">Detailed Risk Assessments<\/a> an ausgew\u00e4hlten Produktionsstandorten der BASF in Asien und Amerika durchzuf\u00fchren. Die <a href=\"https:\/\/www.process.vogel.de\/yokogawa-soll-sicherheit-von-basf-anlagen-in-asien-und-amerika-verbessern-a-660912\/?cmp=beleg-mail\">Process<\/a> berichtete am 9. November bereits dar\u00fcber. Bei den Detailed Risk Assesments werden alle Aspekte der Automation Security vor Ort untersucht. Und anschlie\u00dfend Handlungsempfehlungen zur Verbesserung der Anlagensicherheit sowie zu deren Umsetzung formuliert. Das Projekt ist planm\u00e4\u00dfig im Oktober 2017 gestartet und soll bis Ende 2021 abgeschlossen sein.<\/p>\n<p>Wir informieren Sie gerne dar\u00fcber, wie Sie ein ganzheitliches Sicherheitskonzept realisieren, um Ihre Organisation zu sch\u00fctzen. Denn <a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/tag\/security\/\">Security<\/a> ist ein Thema, das die gesamte Organisation angeht.<\/p>\n<p><strong>Haben Sie Fragen oder Anmerkungen? Wollen Sie mehr wissen \u00fcber DRA? Dann schreiben Sie es in die Kommentare.<\/strong><\/p>\n<p>Begeben Sie sich mit uns auf den <strong>&#8220;Path to Security&#8221;<\/strong>. Folgen Sie diesem Blog. Spannende Beitr\u00e4ge in den n\u00e4chsten Wochen.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch. <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\"> <span class=\"screen-reader-text\">Path to Security &#8211; Detailed Risk Assesments<\/span> Weiterlesen &raquo;<\/a><\/p>\n","protected":false},"author":117,"featured_media":5598,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[957,954,961],"tags":[1018,1136,82,208,212,1137,1138,73,988,74,963,1139,999],"coauthors":[693],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Path to Security - Detailed Risk Assesments - Chemical Pharma Blog<\/title>\n<meta name=\"description\" content=\"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Path to Security - Detailed Risk Assesments\" \/>\n<meta property=\"og:description\" content=\"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-13T12:22:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-17T05:53:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1688\" \/>\n\t<meta property=\"og:image:height\" content=\"1125\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fatma Evren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\"},\"author\":{\"name\":\"Fatma Evren\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad\"},\"headline\":\"Path to Security &#8211; Detailed Risk Assesments\",\"datePublished\":\"2017-11-13T12:22:28+00:00\",\"dateModified\":\"2022-06-17T05:53:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\"},\"wordCount\":362,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\"},\"keywords\":[\"Analyse\",\"Anlagensicherheit\",\"Automation\",\"Automation Security\",\"Cyber Security\",\"Detailed risk assessments\",\"DRA\",\"Safety\",\"Schutz\",\"Security\",\"Sicherheit\",\"Sicherheitskonzept\",\"Verbesserung\"],\"articleSection\":[\"Automation\",\"Safety &amp; Security\",\"Security\"],\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\",\"name\":\"Path to Security - Detailed Risk Assesments - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website\"},\"datePublished\":\"2017-11-13T12:22:28+00:00\",\"dateModified\":\"2022-06-17T05:53:03+00:00\",\"description\":\"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Path to Security &#8211; Detailed Risk Assesments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad\",\"name\":\"Fatma Evren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/image\/705d9e7d4dc124ce066ce1502b785235\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g\",\"caption\":\"Fatma Evren\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/fatma-evren\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Path to Security - Detailed Risk Assesments - Chemical Pharma Blog","description":"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/","og_locale":"de_DE","og_type":"article","og_title":"Path to Security - Detailed Risk Assesments","og_description":"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch.","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2017-11-13T12:22:28+00:00","article_modified_time":"2022-06-17T05:53:03+00:00","og_image":[{"width":1688,"height":1125,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M.jpg","type":"image\/jpeg"}],"author":"Fatma Evren","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/"},"author":{"name":"Fatma Evren","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad"},"headline":"Path to Security &#8211; Detailed Risk Assesments","datePublished":"2017-11-13T12:22:28+00:00","dateModified":"2022-06-17T05:53:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/"},"wordCount":362,"commentCount":1,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"keywords":["Analyse","Anlagensicherheit","Automation","Automation Security","Cyber Security","Detailed risk assessments","DRA","Safety","Schutz","Security","Sicherheit","Sicherheitskonzept","Verbesserung"],"articleSection":["Automation","Safety &amp; Security","Security"],"inLanguage":"de-DE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/","name":"Path to Security - Detailed Risk Assesments - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website"},"datePublished":"2017-11-13T12:22:28+00:00","dateModified":"2022-06-17T05:53:03+00:00","description":"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch.","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/path-to-security-detailed-risk-assesments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/"},{"@type":"ListItem","position":2,"name":"Path to Security &#8211; Detailed Risk Assesments"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad","name":"Fatma Evren","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/image\/705d9e7d4dc124ce066ce1502b785235","url":"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g","caption":"Fatma Evren"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/fatma-evren\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M.jpg",1688,1125,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M-768x512.jpg",768,512,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M.jpg",1688,1125,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_177911741_M-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Fatma Evren","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/fatma-evren\/"},"uagb_comment_info":1,"uagb_excerpt":"Sog. Detailed Risk Assesments (DRA), bei denen alle Aspekte der Automation Security untersucht werden, f\u00fchrt Yokogawa f\u00fcr die BASF SE durch. Path to Security &#8211; Detailed Risk Assesments Weiterlesen &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/5597"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/users\/117"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/comments?post=5597"}],"version-history":[{"count":1,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/5597\/revisions"}],"predecessor-version":[{"id":9808,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/5597\/revisions\/9808"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media\/5598"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media?parent=5597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/categories?post=5597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/tags?post=5597"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/coauthors?post=5597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}